Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development

MLL-AF4+ infant B cell acute lymphoblastic leukemia is characterized by an early onset and dismal survival. It initiates before birth, and very little is known about the early stages of the disease’s development. Using a conditional Mll-AF4-expressing mouse model in which fusion expression is target...

Full description

Bibliographic Details
Main Authors: Neil A. Barrett, Camille Malouf, Chrysa Kapeni, Wendi A. Bacon, George Giotopoulos, Sten Eirik W. Jacobsen, Brian J. Huntly, Katrin Ottersbach
Format: Article
Language:English
Published: Elsevier 2016-07-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124716308002
id doaj-6876b78c7636415d93054bf2cab58c7a
record_format Article
spelling doaj-6876b78c7636415d93054bf2cab58c7a2020-11-25T01:13:26ZengElsevierCell Reports2211-12472016-07-011641039105410.1016/j.celrep.2016.06.046Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in DevelopmentNeil A. Barrett0Camille Malouf1Chrysa Kapeni2Wendi A. Bacon3George Giotopoulos4Sten Eirik W. Jacobsen5Brian J. Huntly6Katrin Ottersbach7Department of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKHaematopoietic Stem Cell Biology Laboratory, MRC Molecular Haematology Unit, Weatherall Institute for Molecular Medicine, University of Oxford, Oxford OX3 9DS, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKDepartment of Haematology, Cambridge Institute for Medical Research, Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UKMLL-AF4+ infant B cell acute lymphoblastic leukemia is characterized by an early onset and dismal survival. It initiates before birth, and very little is known about the early stages of the disease’s development. Using a conditional Mll-AF4-expressing mouse model in which fusion expression is targeted to the earliest definitive hematopoietic cells generated in the mouse embryo, we demonstrate that Mll-AF4 imparts enhanced B lymphoid potential and increases repopulation and self-renewal capacity during a putative pre-leukemic state. This occurs between embryonic days 12 and 14 and manifests itself most strongly in the lymphoid-primed multipotent progenitor population, thus pointing to a window of opportunity and a potential cell of origin. However, this state alone is insufficient to generate disease, with the mice succumbing to B cell lymphomas only after a long latency. Future analysis of the molecular details of this pre-leukemic state will shed light on additional events required for progression to acute leukemia.http://www.sciencedirect.com/science/article/pii/S2211124716308002
collection DOAJ
language English
format Article
sources DOAJ
author Neil A. Barrett
Camille Malouf
Chrysa Kapeni
Wendi A. Bacon
George Giotopoulos
Sten Eirik W. Jacobsen
Brian J. Huntly
Katrin Ottersbach
spellingShingle Neil A. Barrett
Camille Malouf
Chrysa Kapeni
Wendi A. Bacon
George Giotopoulos
Sten Eirik W. Jacobsen
Brian J. Huntly
Katrin Ottersbach
Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development
Cell Reports
author_facet Neil A. Barrett
Camille Malouf
Chrysa Kapeni
Wendi A. Bacon
George Giotopoulos
Sten Eirik W. Jacobsen
Brian J. Huntly
Katrin Ottersbach
author_sort Neil A. Barrett
title Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development
title_short Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development
title_full Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development
title_fullStr Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development
title_full_unstemmed Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development
title_sort mll-af4 confers enhanced self-renewal and lymphoid potential during a restricted window in development
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2016-07-01
description MLL-AF4+ infant B cell acute lymphoblastic leukemia is characterized by an early onset and dismal survival. It initiates before birth, and very little is known about the early stages of the disease’s development. Using a conditional Mll-AF4-expressing mouse model in which fusion expression is targeted to the earliest definitive hematopoietic cells generated in the mouse embryo, we demonstrate that Mll-AF4 imparts enhanced B lymphoid potential and increases repopulation and self-renewal capacity during a putative pre-leukemic state. This occurs between embryonic days 12 and 14 and manifests itself most strongly in the lymphoid-primed multipotent progenitor population, thus pointing to a window of opportunity and a potential cell of origin. However, this state alone is insufficient to generate disease, with the mice succumbing to B cell lymphomas only after a long latency. Future analysis of the molecular details of this pre-leukemic state will shed light on additional events required for progression to acute leukemia.
url http://www.sciencedirect.com/science/article/pii/S2211124716308002
work_keys_str_mv AT neilabarrett mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment
AT camillemalouf mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment
AT chrysakapeni mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment
AT wendiabacon mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment
AT georgegiotopoulos mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment
AT steneirikwjacobsen mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment
AT brianjhuntly mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment
AT katrinottersbach mllaf4confersenhancedselfrenewalandlymphoidpotentialduringarestrictedwindowindevelopment
_version_ 1725162335465635840